Inventor
ROYALTY SUSAN M
US30 patents
⚠️ This page may combine multiple inventors who share the name “ROYALTY SUSAN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AERIE PHARMACEUTICALS INC
23 patentsUS9096569B2Aug 4, 2015
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC40 citations98
US8921392B2Dec 30, 2014
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC38 citations98
US8716310B2May 6, 2014
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC49 citations98
US8357699B2Jan 22, 2013
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC42 citations98
US8034943B2Oct 11, 2011
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC49 citations98
US7671205B2Mar 2, 2010
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC61 citations98
US10174017B2Jan 8, 2019
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC41 citations97
US10899714B2Jan 26, 2021
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC10 citations94
US10882840B2Jan 5, 2021
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC10 citations94
US10654844B2May 19, 2020
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC11 citations94
US10112920B2Oct 30, 2018
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC20 citations94
US9884840B2Feb 6, 2018
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC25 citations94
US10532993B2Jan 14, 2020
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC9 citations93
US9951059B2Apr 24, 2018
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC10 citations93
US10316029B2Jun 11, 2019
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC10 citations92
US9365518B2Jun 14, 2016
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC10 citations92
US11028081B2Jun 8, 2021
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC6 citations84
US11021456B2Jun 1, 2021
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC5 citations84
US10472327B2Nov 12, 2019
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC6 citations84
US9963432B2May 8, 2018
Beta-amino-isoquinolinyl amide compounds
AERIE PHARMACEUTICALS INC10 citations84
US9890123B2Feb 13, 2018
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC5 citations84
US9512101B2Dec 6, 2016
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC6 citations84
US11618748B2Apr 4, 2023
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC1 citations73
DELONG MITCHELL A
7 patentsUS8759388B2Jun 24, 2014
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
DELONG MITCHELL A39 citations98
US8450344B2May 28, 2013
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
DELONG MITCHELL A51 citations98
US8394826B2Mar 12, 2013
Dual mechanism inhibitors for the treatment of disease
DELONG MITCHELL A57 citations98
US8455647B2Jun 4, 2013
6-aminoisoquinoline compounds
DELONG MITCHELL A44 citations97
US8455513B2Jun 4, 2013
6-aminoisoquinoline compounds
DELONG MITCHELL A44 citations97
US8455514B2Jun 4, 2013
6-and 7-amino isoquinoline compounds and methods for making and using the same
DELONG MITCHELL A43 citations97
US8871757B2Oct 28, 2014
6-and 7-amino isoquinoline compounds and methods for making and using the same
DELONG MITCHELL A36 citations94